SXTC SXT Pharmaceuticals Bozor qiymatining balans qiymatiga nisbati

sxtchina.com (SXTC) - korporativ logo

China SXT Pharmaceuticals (SXTC) mijozlarni jalb qilishni oshirish uchun qishloq xo'jaligi sektori va chakana savdoni integratsiya qilgan holda, Xitoy dori vositalari uchun yopiq ishlab chiqarish siklini yaratmoqda. Ushbu kunlik narxlar grafigi aktivning momentumini tasdiqlaydi, bunda uning ko'rsatkichi 0.00 darajasida qotgan. Biroq, likvidlik yetishmovchiligi va Xitoy Xalq Respublikasi tartibga soluvchi organlarining bosimi ma'lum qiyinchiliklarni yuzaga keltirmoqda. Shu bilan birga, China SXT Pharmaceuticals (SXTC) preparatlarni ekstraksiya qilish va qadoqlashni avtomatlashtirish uchun intellektual tizimlarni joriy etmoqda.

sxtchina.com (SXTC) - Balans qiymatiga nisbatan bozor qiymati 04.07.2022dan 29.10.2026gacha

China SXT Pharmaceuticals (SXTC) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiya kursi va ekspertlarning narx prognozi:
Aksiya narxi sxtchina.com|SXTC - Konsensus maqsadli narx
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati SXT China|SXTC - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati China SXT Pharmaceuticals|SXTC - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati sxtchina.com|SXTC - Kompaniyaning umumiy aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati China SXT Pharmaceuticals|SXTC - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati sxtchina.com|SXTC - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar SXT China|SXTC - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari China SXT Pharmaceuticals|Tezkor likvidlik sxtchina.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
SXTC - Kompaniyaning sof daromadi
Kompaniyaning asosiy tahlili:SXT Pharmaceuticals - SXTC
sxtchina.com ishlab chiqargan mahsulot

Haddan tashqari qimmat baholangan aktivlarni saralab olish uchun investorlar kapital premiumining darajasini aniqlash maqsadida bozor qiymatini sof aktivlar bilan solishtiradilar. Buxgalteriya qiymatiga nisbatan narx koeffitsientini tahlil qilish China SXT Pharmaceuticals (SXTC) kompaniyasining aktivlar sifatini baholash imkonini beradi, bunda fitofarmatsevtika vositalarining diversifikatsiyalashgan portfeli va keng tarqatish tarmog'i tartibga soluvchi o'zgarishlar risklarini yumshatgan holda bozor premiumini asoslaydi.

Raqobatchilar tahlili

HLN: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati kenvue.com|Bozor qiymatining balans qiymatiga nisbati Verona Pharma|Jyong Biotech Limited - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati LGND|AMRX (Amneal Corp) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|Bozor kapitallashuvining balans qiymatiga nisbati alvotech.com ALVO|LQDA - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati GLPG (Galapagos N.V.)|ANI Pharma (ANIP) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Afrezza|AMPH (Amphastar Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pacira.com|Kapitallashuvning sof aktivlarga nisbati SPRY (ARS Pharmaceuticals, Inc.)|TBPH (Theravance Biopharma Inc) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Aquestive Pharma AQST|scPharmaceuticals, Inc. (SCPH) - Bozor qiymatining balans qiymatiga koeffitsiyenti|TECX: Kapitallashuvning sof aktivlarga nisbati|tonixpharma.com - Bozor kapitallashuvining balans qiymatiga multiplikatori|EPRX: Bozor kapitallashuvining balans qiymatiga nisbati|BioHarvest Sciences, Inc. - Balans qiymatiga nisbatan bozor qiymati|EXOZ (Invizyne Technologies, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Oramed Pharma ORMP|Bozor qiymatining balans qiymatiga nisbati Entera Bio Ltd. (ENTX)|HYFT (ipatherapeutics.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati ABVC (ABVC BioPharma, Inc.)|CPIX - Kapitallashuvning sof aktivlarga nisbati|Quantum BioPharma Limited - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati FGEN (FibroGen Corporation)|TELO: Bozor kapitallashuvining balans qiymatiga nisbati|RANI - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Synergy CHC Corp.|Kapitallashuvning balans qiymatiga nisbati RLYB (Rallybio Corp.)|Bozor kapitallashuvining balans qiymatiga nisbati LEXX|Bozor kapitallashuvining balans qiymatiga nisbati Pulmatrix Corporation (PULM)|Pheton Holdings - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati APM|LYRA - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi impactbiomedinc.com IBO|TNFA (tnfpharma.com) - Kapitallashuvning sof aktivlarga nisbati|Kapitallashuvning balans qiymatiga nisbati YCBD|Kapitallashuvning sof aktivlarga nisbati PRFX|CYTO (Auris Medical) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Kapitallashuvning sof aktivlarga nisbati LIPO (Lipella Pharmaceuticals, Inc.)|OPTN (OptiNose Inc) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Pieris PIRS|PROC (Procaps Group Corp) - Sof aktivlarga nisbatan bozor kapitallashuvi|Petros Pharmaceuticals - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati QLI (qlsyy.net)|SLRN: Bozor kapitallashuvining balans qiymatiga nisbati|TFF Pharmaceuticals Inc. (TFFP) - Bozor kapitallashuvining balans qiymatiga nisbati